IL6 and metabolic syndrome: In this regard, in our previous study, we also found a significant reduction of insulin resistance, together with increased circulating levels of adiponectin and decreased concentrations of IL-6 in mice with MetS supplemented with CSAT+®, without significant changes in adiposity [18].